NSCLC: Case for Combining Chemo and Osimertinib NSCLC: Case for Combining Chemo and Osimertinib

Mark G. Kris, MD, discusses perioperative therapy for locally advanced lung cancer and the potential implications for survival and cure.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news